Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Ltd.13.49833824250663.3926
Domestic EquitiesDr. Reddy's Laboratories Ltd.8.94603842525439.6617
Domestic EquitiesCipla Ltd.8.84763015025434.8269
Domestic EquitiesDivi's Laboratories Ltd.6.7057570624329.5610
Domestic EquitiesAurobindo Pharma Ltd.5.30092244911260.5219
Domestic EquitiesLupin Ltd.4.72711145591232.3201
Domestic EquitiesAlkem Laboratories Ltd.4.4244445422217.4417
Domestic EquitiesMankind Pharma Ltd3.4981709021171.9199
Domestic EquitiesGland Pharma Ltd.3.38631045125166.4257
Domestic EquitiesZydus Lifesciences Ltd.3.10031718945152.3673
Domestic EquitiesApollo Hospitals Enterprise Ltd.2.8197209454138.5790
Domestic EquitiesSyngene International Ltd.2.10691425869103.5466
Domestic EquitiesAtul Ltd.1.931515468994.9265
Domestic EquitiesWindlas Biotech Ltd.1.815885765189.2386
Domestic EquitiesPfizer Ltd.1.770021723186.9902
Domestic EquitiesAlembic Pharmaceuticals Ltd.1.647687092880.9745
Domestic EquitiesMedplus Health Services Ltd1.541799695975.7689
Domestic EquitiesSBI Life Insurance Company Ltd.1.478246934972.6482
Domestic EquitiesBiocon Ltd.1.4441207706770.9734
Domestic EquitiesAdvanced Enzyme Technologies Ltd.1.4305251570970.3015
Domestic EquitiesMedi Assist Healthcare Services Ltd1.3541146233866.5510
Domestic EquitiesShilpa Medicare Ltd.1.300196314963.8953
Domestic EquitiesFine Organic Industries Ltd.1.225015024360.2024
Domestic EquitiesGlenmark Pharmaceuticals Ltd.1.187837882258.3784
Domestic EquitiesSanofi Consumer Healthcare India Ltd1.052810719951.7423
Domestic EquitiesAstrazeneca Pharma India Ltd.1.05126002151.6640
Domestic EquitiesAarti Industries Ltd.1.0490131934751.5535
Domestic EquitiesThyrocare Technologies Ltd.1.035974905750.9097
Domestic EquitiesYatharth Hospital & Trauma Care Services Pvt Ltd1.0041116192549.3470
Domestic EquitiesAarti Drugs Ltd.0.9614138852347.2514
Domestic EquitiesFDC Ltd.0.9601119768947.1830
Domestic EquitiesSun Pharma Advanced Research Co. Ltd0.8661287785142.5663
Domestic EquitiesProcter & Gamble Health Ltd.0.81697801240.1489
Domestic EquitiesMax Financial Services Ltd.0.787533723038.7039
Domestic EquitiesSenores Pharmaceuticals Ltd0.744164088336.5688
Domestic EquitiesStar Health & Allied Insurance0.656590462132.2633
Domestic EquitiesEmcure Pharmaceuticals Ltd.0.649429761231.9159
Domestic EquitiesUnichem Laboratories Ltd.0.349024610517.1511
Domestic EquitiesAlivus Life Sciences Ltd.0.282112822813.8634
Domestic EquitiesLaxmi Organic Industries Ltd.0.241667764811.8758
Domestic EquitiesLaxmi Dental Ltd.0.18842080199.2600
Domestic EquitiesGalaxy Surfactants Ltd.0.1009242114.9593
Total 98.2847 4830.3409
Cash & Cash Equivalents and Net AssetsTREPS1.4063 69.1163
Cash & Cash Equivalents and Net AssetsCash Margin - Derivatives0.1710 8.4052
Cash & Cash Equivalents and Net AssetsNet Current Assets0.1379 6.7774
Total 1.7153 84.2989
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.